Engineering a Hydrogen Sulfide-based Nanomodulator to Normalize Hyperactive Photothermal Immunogenicity for Combination Cancer Therapy. Adv. Mater., 2021, 33, 2008481.
Engineering a Hydrogen Sulfide-based Nanomodulator to Normalize Hyperactive Photothermal Immunogenicity for Combination Cancer Therapy. Adv. Mater., 2021, 33, 2008481.